List of Tables
Table 1. Eosinophilic Esophagitis Drug Market Trends
Table 2. Eosinophilic Esophagitis Drug Market Drivers & Opportunity
Table 3. Eosinophilic Esophagitis Drug Market Challenges
Table 4. Eosinophilic Esophagitis Drug Market Restraints
Table 5. Global Eosinophilic Esophagitis Drug Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Eosinophilic Esophagitis Drug Revenue Market Share by Company (2020-2025)
Table 7. Global Eosinophilic Esophagitis Drug Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Eosinophilic Esophagitis Drug Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Eosinophilic Esophagitis Drug Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Eosinophilic Esophagitis Drug Manufacturing Base and Headquarters
Table 11. Key Manufacturers Eosinophilic Esophagitis Drug Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Eosinophilic Esophagitis Drug
Table 13. Global Eosinophilic Esophagitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Esophagitis Drug as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Eosinophilic Esophagitis Drug Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Eosinophilic Esophagitis Drug Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Eosinophilic Esophagitis Drug Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Type (2020-2025)
Table 20. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Type (2026-2031)
Table 21. Global Eosinophilic Esophagitis Drug Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Eosinophilic Esophagitis Drug Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Eosinophilic Esophagitis Drug Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Eosinophilic Esophagitis Drug Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Eosinophilic Esophagitis Drug Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Eosinophilic Esophagitis Drug Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Eosinophilic Esophagitis Drug Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Eosinophilic Esophagitis Drug Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Application (2020-2025)
Table 32. Global Eosinophilic Esophagitis Drug Sales Market Share in Value by Application (2026-2031)
Table 33. Global Eosinophilic Esophagitis Drug Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Eosinophilic Esophagitis Drug Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Eosinophilic Esophagitis Drug Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Eosinophilic Esophagitis Drug Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Eosinophilic Esophagitis Drug Price by Application (2020-2025) & (USD/Unit)
Table 39. Global Eosinophilic Esophagitis Drug Price by Application (2026-2031) & (USD/Unit)
Table 40. Global Eosinophilic Esophagitis Drug Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Eosinophilic Esophagitis Drug Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Eosinophilic Esophagitis Drug Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Eosinophilic Esophagitis Drug Sales Value by Region (2020-2025) & (%)
Table 44. Global Eosinophilic Esophagitis Drug Sales Value by Region (2026-2031) & (%)
Table 45. Global Eosinophilic Esophagitis Drug Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Eosinophilic Esophagitis Drug Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Eosinophilic Esophagitis Drug Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Eosinophilic Esophagitis Drug Sales Volume by Region (2020-2025) & (%)
Table 49. Global Eosinophilic Esophagitis Drug Sales Volume by Region (2026-2031) & (%)
Table 50. Global Eosinophilic Esophagitis Drug Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Eosinophilic Esophagitis Drug Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Eosinophilic Esophagitis Drug Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Eosinophilic Esophagitis Drug Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Eosinophilic Esophagitis Drug Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Eosinophilic Esophagitis Drug Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Eosinophilic Esophagitis Drug Sales Volume, (2026-2031) & (K Units)
Table 57. AstraZeneca Company Information
Table 58. AstraZeneca Introduction and Business Overview
Table 59. AstraZeneca Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. AstraZeneca Eosinophilic Esophagitis Drug Product Offerings
Table 61. AstraZeneca Recent Development
Table 62. GSK Company Information
Table 63. GSK Introduction and Business Overview
Table 64. GSK Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. GSK Eosinophilic Esophagitis Drug Product Offerings
Table 66. GSK Recent Development
Table 67. Bayer Company Information
Table 68. Bayer Introduction and Business Overview
Table 69. Bayer Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Bayer Eosinophilic Esophagitis Drug Product Offerings
Table 71. Bayer Recent Development
Table 72. Adare Pharmaceuticals Company Information
Table 73. Adare Pharmaceuticals Introduction and Business Overview
Table 74. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Adare Pharmaceuticals Eosinophilic Esophagitis Drug Product Offerings
Table 76. Adare Pharmaceuticals Recent Development
Table 77. DBV Technologies Company Information
Table 78. DBV Technologies Introduction and Business Overview
Table 79. DBV Technologies Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. DBV Technologies Eosinophilic Esophagitis Drug Product Offerings
Table 81. DBV Technologies Recent Development
Table 82. Dr. Falk Pharma Company Information
Table 83. Dr. Falk Pharma Introduction and Business Overview
Table 84. Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Dr. Falk Pharma Eosinophilic Esophagitis Drug Product Offerings
Table 86. Dr. Falk Pharma Recent Development
Table 87. Quorum Innovations Company Information
Table 88. Quorum Innovations Introduction and Business Overview
Table 89. Quorum Innovations Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Quorum Innovations Eosinophilic Esophagitis Drug Product Offerings
Table 91. Quorum Innovations Recent Development
Table 92. Takeda Company Information
Table 93. Takeda Introduction and Business Overview
Table 94. Takeda Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Takeda Eosinophilic Esophagitis Drug Product Offerings
Table 96. Takeda Recent Development
Table 97. Calypso Company Information
Table 98. Calypso Introduction and Business Overview
Table 99. Calypso Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Calypso Eosinophilic Esophagitis Drug Product Offerings
Table 101. Calypso Recent Development
Table 102. Celgene Company Information
Table 103. Celgene Introduction and Business Overview
Table 104. Celgene Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Celgene Eosinophilic Esophagitis Drug Product Offerings
Table 106. Celgene Recent Development
Table 107. Regeneron Company Information
Table 108. Regeneron Introduction and Business Overview
Table 109. Regeneron Eosinophilic Esophagitis Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Regeneron Eosinophilic Esophagitis Drug Product Offerings
Table 111. Regeneron Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Eosinophilic Esophagitis Drug Downstream Customers
Table 115. Eosinophilic Esophagitis Drug Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Eosinophilic Esophagitis Drug Product Picture
Figure 2. Global Eosinophilic Esophagitis Drug Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Eosinophilic Esophagitis Drug Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Eosinophilic Esophagitis Drug Sales Volume (2020-2031) & (K Units)
Figure 5. Global Eosinophilic Esophagitis Drug Sales Price (2020-2031) & (USD/Unit)
Figure 6. Eosinophilic Esophagitis Drug Report Years Considered
Figure 7. Global Eosinophilic Esophagitis Drug Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Eosinophilic Esophagitis Drug Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Eosinophilic Esophagitis Drug Revenue in 2024
Figure 10. Eosinophilic Esophagitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Budesonide Picture
Figure 12. Fluticasone Picture
Figure 13. Others Picture
Figure 14. Global Eosinophilic Esophagitis Drug Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Eosinophilic Esophagitis Drug Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Eosinophilic Esophagitis Drug Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Eosinophilic Esophagitis Drug Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Eosinophilic Esophagitis Drug Price by Type (2020-2031) & (USD/Unit)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Clinics
Figure 21. Product Picture of Drugstore
Figure 22. Global Eosinophilic Esophagitis Drug Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Eosinophilic Esophagitis Drug Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Eosinophilic Esophagitis Drug Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Eosinophilic Esophagitis Drug Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Eosinophilic Esophagitis Drug Price by Application (2020-2031) & (USD/Unit)
Figure 27. North America Eosinophilic Esophagitis Drug Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Eosinophilic Esophagitis Drug Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Eosinophilic Esophagitis Drug Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Eosinophilic Esophagitis Drug Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Eosinophilic Esophagitis Drug Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Eosinophilic Esophagitis Drug Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Eosinophilic Esophagitis Drug Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Eosinophilic Esophagitis Drug Sales Volume (%), (2020-2031)
Figure 39. United States Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Eosinophilic Esophagitis Drug Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Eosinophilic Esophagitis Drug Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Eosinophilic Esophagitis Drug Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Eosinophilic Esophagitis Drug Sales Value by Application (%), 2024 VS 2031
Figure 45. China Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Eosinophilic Esophagitis Drug Sales Value by Type (%), 2024 VS 2031
Figure 47. China Eosinophilic Esophagitis Drug Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Eosinophilic Esophagitis Drug Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Eosinophilic Esophagitis Drug Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Eosinophilic Esophagitis Drug Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Eosinophilic Esophagitis Drug Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Eosinophilic Esophagitis Drug Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Eosinophilic Esophagitis Drug Sales Value by Application (%), 2024 VS 2031
Figure 57. India Eosinophilic Esophagitis Drug Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Eosinophilic Esophagitis Drug Sales Value by Type (%), 2024 VS 2031
Figure 59. India Eosinophilic Esophagitis Drug Sales Value by Application (%), 2024 VS 2031
Figure 60. Eosinophilic Esophagitis Drug Industrial Chain
Figure 61. Eosinophilic Esophagitis Drug Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
